Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy

被引：0
|
作者：
Huimin Wang
Ziru Yan
Minyue Dong
Xiaojun Zhu
Hanzhi Wang
Zhengping Wang
机构：
[1] Women’s Hospital,
[2] School of Medicine,undefined
[3] Zhejiang University,undefined
来源：
Archives of Gynecology and Obstetrics | 2012年 / 285卷
关键词：
Intrahepatic cholestasis of pregnancy; OATPs; Placenta; Bile acids; Fetal risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1535 / 1540
页数：5
相关论文
共 50 条
  • [11] Expression of the organic anion transporters OATP1B1, OATP1B3, and OATP2B1 in human liver is affected by genetic and nongenetic factors
    Nies, A.
    Winter, S.
    Burk, O.
    Klein, K.
    Zanger, U. M.
    Stieger, B.
    Schwab, M.
    Schaeffeler, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 80 - 80
  • [12] Nuclear receptor ligands interact with the human liver transporters OATP1B1 and OATP1B3
    Hagenbuch, BH
    Obaidat, A
    Thompson, L
    FASEB JOURNAL, 2006, 20 (05): : A1143 - A1143
  • [13] Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3
    Katuwal, Miki
    Schnegelberger, Regina
    Wityk, Elliott
    Ruggiero, Melissa
    Hagenbuch, Bruno
    FASEB JOURNAL, 2016, 30
  • [14] The effect of well-known inhibitors of efflux transporters on the uptake transporters, OATP1B1 and OATP1B3
    Matsushima, Soichiro
    Maeda, Kazuya
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2006, 38 : 60 - 61
  • [15] Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
    Hirano, M
    Maeda, K
    Shitara, Y
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01): : 139 - 146
  • [16] Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP
    Koenig, Joerg
    Klatt, Sabine
    Dilger, Karin
    Fromm, Martin F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 81 - 86
  • [17] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Anne T Nies
    Mikko Niemi
    Oliver Burk
    Stefan Winter
    Ulrich M Zanger
    Bruno Stieger
    Matthias Schwab
    Elke Schaeffeler
    Genome Medicine, 5
  • [18] HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
    Hartkoorn, Ruben C.
    San Kwan, Wai
    Shallcross, Victoria
    Chaikan, Ammara
    Liptrott, Neill
    Egan, Deirdre
    Sora, Enrique Salcedo
    James, Chloe E.
    Gibbons, Sara
    Bray, Pat G.
    Back, David J.
    Khoo, Saye H.
    Owen, Andrew
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (02): : 112 - 120
  • [19] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Nies, Anne T.
    Niemi, Mikko
    Burk, Oliver
    Winter, Stefan
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    GENOME MEDICINE, 2013, 5
  • [20] Digoxin is not a substrate for organic anion transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium dependent transporter expressed in HEK293 cells
    Taub, Mitchell E.
    Mease, Kirsten
    Sane, Rucha S.
    Watson, Cory A.
    Chen, Liangfu
    Ellens, Harma
    Hirakawa, Brad
    Reyner, Eric L.
    Jani, Marton
    Lee, Caroline A.
    DRUG METABOLISM REVIEWS, 2011, 43 : 195 - 196
12345